Endocrine Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

Phase II Study of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Condition:   Breast Cancer Brain Metastases Intervention:   Drug: SPH4336 Tablets Sponsor:   Shanghai Pharmaceuticals Holding Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2023 Category: Research Source Type: clinical trials

Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases.
Condition:   Breast Cancer Brain Metastases Intervention:   Drug: SPH4336 Tablets Sponsor:   Shanghai Pharmaceuticals Holding Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2023 Category: Research Source Type: clinical trials

Dalpiciclib With Endocrine Therapy for Advanced Breast Cancer After CDK4/6 Inhibitor Failure (DAWNA-FES)
Condition:   Advanced Breast Cancer Interventions:   Drug: The combination of Dalpiciclib with physician-selected endocrine therapy;   Drug: Chemotherapy selected by the physician Sponsors:   Peking Union Medical College Hospital;   Jiangsu HengRui Medicine Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2023 Category: Research Source Type: clinical trials